Overview
D3 Labs is a fintech company founded in 2022, focusing on leveraging blockchain technology to simplify and empower finance. Their mission is to deliver confidence and benefits through seamless blockchain adoption, facilitating financial transformation in Southeast Asia, with initial efforts concentrated in Indonesia.
Products and Solutions
D3 Labs specializes in developing blockchain-based financial management platforms. They offer a multi-asset management system for enterprises, enabling automation of routine tasks such as payments, compliance checks, and record-keeping, thereby boosting business efficiency. One of their flagship products, SeaSeed, provides digital asset solutions, enhancing operational efficiency and security for businesses.
Key Offerings
- Programmable Assets: A solution to bridge the gap between underserved communities and the formal financial sector, promoting digital financial services with seamless and secure transactions.
- Sandbox Model: Allows businesses to test proofs of concept prior to substantial investments.
- Diverse Sector Applications: Serving sectors like banking, supply chain, and e-commerce, improving transparency, traceability, and interoperability.
Leadership Team
- Chung Ying Lai, Co-CEO - Actively involved in promoting asset tokenization in Indonesia.
- Tigran Adiwirya, Co-CEO - Focuses on advancing blockchain initiatives within stringent regulatory environments.
- Adytia Raflein, COO - Over 16 years in journalism and marketing; previously served as Chief Marketing Officer.
- Khun Ling, CTO - Experienced full-stack JavaScript developer.
- Hong Loon Gan, Business Director - Co-founder with C-suite level experience in investments and advisory roles.
- Chris Tang, VP of Finance - Specializes in operating within the fintech and blockchain ecosystems.
- Jeremy Low, VP of Product - Interests in digital assets and blockchain applications, with past experience at Tokocrypto.
Financials and Funding
D3 Labs has raised funding from 8 investors, including Signum Capital and Arkana Capital. Their notable funding activity includes a Pre-Seed round in April 2023. Their Series A funding round, closed in January 2025 and led by Paradigm, raised $25 million, demonstrating strong investor confidence in their growth potential and strategic direction.
Strategic Initiatives
The company is committed to promoting financial inclusion in Southeast Asia by equipping regional businesses with the necessary blockchain infrastructure. They emphasize empowering businesses and communities, contributing to economic development while promoting transparency, security, and efficient value transfer.
Contact Information
- Website: [d3labs.io](https://d3labs.io/)
- Email: hello@d3labs.io
- LinkedIn: [D3 Labs LinkedIn Profile](https://sg.linkedin.com/company/d3labsio)
Competitive Landscape
D3 Labs operates within a competitive landscape across various sectors and services, facing significant competition from firms in the Multimedia & Graphic Design industry. The company generates revenue ranging from $5M to $10M with a workforce spanning 20 to 49 employees. Notable competitors include Luno, Galaxy, Uphold, Coins.ph, Matrixport, Consensys, BlockFi, and Abra. Additionally, competitors from associated industries include IQVIA India, Medpace, and PPD.
Notable Competitors
- IQVIA: A leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Headquartered in Bangalore, Karnataka, IQVIA employs over 15,000 people in India alone. The company leverages expansive healthcare data sources and domain expertise to innovate business models and provide real-time operational insights.
- Medpace: A full-service clinical contract research organization offering comprehensive Phase I-IV clinical development services to the biotechnology and pharmaceutical sectors. With a strong focus on therapeutic expertise in oncology and cardiology, Medpace is headquartered in Cincinnati, OH, and employs approximately 5,800 people across 43 countries.
- PPD: Part of Thermo Fisher Scientific, PPD is a leading contract research organization focused on accelerating drug development through patient-centric strategies and data analytics. With extensive laboratory services and operations in over 20 therapeutic areas, PPD is headquartered in Waltham, Massachusetts.
- Luno and Galaxy: In the cryptocurrency and blockchain domain, D3 Labs contends with London-based Luno, promoting safe cryptocurrency investments, and Galaxy, providing digital asset and blockchain financial services, including asset management and strategic advisory, with a multi-continent presence.
Understanding the breadth and diversity of D3 Labs' competitors across distinct yet overlapping industries underscores the importance of strategic positioning and adaptation to competitive pressures. Each competitor illustrates unique strengths in various industries, necessitating D3 Labs to innovate and potentially diversify its offerings to maintain and enhance its competitive edge.
